Compare LFST & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFST | NOVT |
|---|---|---|
| Founded | 2015 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.0B |
| IPO Year | 2021 | 1999 |
| Metric | LFST | NOVT |
|---|---|---|
| Price | $12.30 | $144.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $9.83 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 4.2M | 396.3K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | ★ $1,424,285,000.00 | $521,290,000.00 |
| Revenue This Year | $17.18 | $8.61 |
| Revenue Next Year | $14.02 | $6.57 |
| P/E Ratio | ★ N/A | $175.56 |
| Revenue Growth | 13.85 | ★ 35.49 |
| 52 Week Low | $4.78 | $98.27 |
| 52 Week High | $12.97 | $176.38 |
| Indicator | LFST | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 60.72 | 41.31 |
| Support Level | $6.38 | $132.80 |
| Resistance Level | $12.97 | $149.42 |
| Average True Range (ATR) | 0.54 | 5.99 |
| MACD | -0.03 | -2.28 |
| Stochastic Oscillator | 72.58 | 14.71 |
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.